DouglasMichaelBurgessMD

Addiction

Associate Professor, Psychiatry, University of Missouri, Kansas City School of Medicine Medical Director of Addiction Services, University Health

Dr. Burgess is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Douglas Burgess is a psychiatrist in Kansas City, MO. He received his medical degree from Saint Louis University School of Medicine and has been in practice 11 years. He specializes in addiction and is experienced in dual diagnosis.

Medical University of South CarolinaFellowship, Addiction Psychiatry, 2010 - 2011
Duke University HospitalResidency, Psychiatry, 2006 - 2010
Saint Louis University School of MedicineClass of 2006

PubMed

41 citations
Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.
Scott H. Stewart, David G. Koch, Douglas M. Burgess, Ira Willner, Adrian Reuben
Alcoholism, Clinical and Experimental Research. 2013-01-01
2 citations
Abuse of tropicamide eye drops: review of clinical data.
Val Bellman, Anastasia Ukolova, Elena Erovichenkova, Sarah Lam, Hirsch K Srivastava
Revista Brasileira De Psiquiatria. 2022-11-05
Claims data analysis of provider-to-provider tele-mentoring program impact on opioid prescribing in Missouri.
Olabode B Ogundele, Xing Song, Praveen Rao, Tracy Greever-Rice, Suzanne A Boren
Journal of Opioid Management. 2024-05-03

Overdose Deaths in Missouri Rose Nearly 20% in 2020. CDC Points to Pandemic, FentanylJuly 20th, 2021
Telehealth Program Created to Improve Access to Specialty Care Found to Reduce Reliance on Opioids in Pain ManagementMay 9th, 2024